Project Grant CLSS00000086186

This $2,570,500 project grant from the Department of Health and Human Services Health Resources and Services Administration supports the development and operation of an integrated substance use disorder training program. Funded under the Mental and Behavioral Health Education and Training Grants program (CFDA 93.732), the award supports a consortium approach to establish a post-graduate training program for nurse practitioners and physician assistants. The program will provide training for these...

This Project Grant award of $799,986.00, provided by the Health Resources and Services Administration (HRSA) under the Mental and Behavioral Health Education and Training Grants program (CFDA 93.732), aims to expand the addiction medicine and addiction psychiatry fellowship programs at Massachusetts General Hospital (MGH) and Brigham and Women's Hospital (BWH). The primary goals are to grow the number of physicians capable of treating patients with substance use disorders, particularly in...

The U.S. Department of Health and Human Services, through the Mental and Behavioral Health Education and Training Grants program (CFDA 93.732), awarded a $599,973 Project Grant to Loma Linda University. The grant aims to address the shortage of addiction medicine specialists in medically underserved and rural communities by training 28 fellows (18 grant-funded) over 5 years through the Addiction Medicine Fellowship (AMF) program. The AMF program will increase the number of board-certified...

This federal Project Grant award of $120,348.00, provided by the U.S. Department of Agriculture (USDA) Rural Utilities Service's Distance Learning and Telemedicine (DLT) Loans and Grants program (CFDA 10.855), supports the Southern Tier Health Care System, Inc. (STHCS) in delivering substance use disorder-related educational services to rural communities in New York. The funding will enable STHCS, a non-profit organization, to utilize telecommunications technologies to remotely provide substance...

This $750,000 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program supports Sanford Medical Center Fargo's efforts to expand substance use disorder (SUD) and co-occurring disorder (COD) treatment services in Southeast North Dakota and Western Minnesota. The project aims to increase access to care by adding virtual care modalities,...

This federal Project Grant award of $375,000.00 from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program supports an ambulatory-based recovery program operated by the nonprofit organization Centro Deambulantes Cristo Pobre in Ponce, Puerto Rico. Over a 3-year period, the program will serve 160 unduplicated individuals experiencing substance use disorders...

The U.S. Department of Health and Human Services' Health Resources and Services Administration (HRSA) awarded a $300,000 Rural Health Care Services Outreach, Rural Health Network Development and Small Health Care Provider Quality Improvement (CFDA 93.912) project grant to the Delaware Division of Substance Abuse and Mental Health (DSAMH). The grant will fund a one-year pilot program to implement a Contingency Management (CM) intervention to address stimulant use disorder and polysubstance use...

This $800,000 Project Grant awarded by the Health Resources and Services Administration (HRSA) under the Mental and Behavioral Health Education and Training Grants (CFDA 93.732) program aims to enhance the Addiction Medicine Fellowship curriculum at the University of California, Los Angeles (UCLA) to improve the ability of addiction medicine fellows to practice primary and secondary prevention and management of opioid use disorder (OUD) in high-need communities. The key objectives include...

The Department of Health and Human Services Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $4.7 million Block Grant to the Georgia Department of Behavioral Health and Developmental Disabilities (DBHDD) for the period of September 1, 2021 through September 30, 2025 under the Block Grants for Prevention and Treatment of Substance Abuse (CFDA 93.959) program. The funding supports several substance abuse prevention and treatment services delivered by DBHDD and various...

The Project Grant award of $400,000 from the National Institute on Drug Abuse (NIDA), provided under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to support the development of "MyTrials", an integrated remote biomarker capture system for decentralized clinical trials focused on substance use disorders. The award, with an end date of March 31, 2026, will enable the awardee, Mountainpass Technology LLC, to refine and expand the capabilities of the MyTrials...